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2Abstract
The polycystic ovary syndrome is a very common disease affecting 6.5% 
of women which is frequently associated with obesity, the link between 
both disorders being insulin resistance. From morbidly obese women 
submitted for surgical treatment of obesity, we obtain intra-abdominal 
adipose tissue samples in order to compare protein patterns between 
women with and without polycystic ovary syndrome by 2-DE analysis. 
Adipose tissue is a complex material extremely rich in lipids, and to 
improve protein solubilisation a lysis buffer including 8.4 M urea, 2.4 M 
thiourea, 5% CHAPS and 50mM DTT was used followed by 
ultracentrifugation to remove fat. Hydroxyethyl disulfide was added to 
increase resolution in the alkaline region [1], and this product 
demonstrates also capable to improve resolution at wide range pH 3-10. 
Our work shows for the first time 2-DE maps and identification of some 
proteins by MS, from human adipose tissue and lays the ground for future 
studies in metabolic diseases such as polycystic ovary syndrome, obesity, 
hypertension and type 2 diabetes.
3Proteomics could be described as the global analysis of gene expression 
at the protein level from a whole organism, a cell culture or a tissue. The 
combined use of 2-DE and MS stands as one of the methods of choice for 
the characterization of complex samples. Recent technical improvements 
related to 2-DE and MS have resulted in increased sensitivity, 
reproducibility and throughput of proteome analysis thereby providing an 
established technological platform [2]. However, additional improvements 
are needed for the analysis of specific proteins such as low-abundant, 
high molecular weight or highly hydrophobic species. On the other hand, 
while wide range pH gradients and ultra-zoom gels appear to work 
properly below pH 7, obtaining a comparable resolution in the alkaline pH 
region is not straightforward [3, 4, 5]. Moreover, samples such as serum, 
cerebrospinal fluid or adipose tissue are especially difficult to study [6]. 
The biochemistry of adipose tissue is of great interest, especially because 
the prevalence of obesity is increasing exponentially in developed 
countries, and obesity plays an important role in the development of type 2 
diabetes, dyslipidemia, polycystic ovary syndrome (PCOS) and 
cardiovascular diseases [7]. Therefore obesity research focuses on the 
identification of regulatory systems and potential targets for drug 
development. Such targets could be found among the genes and proteins 
expressed in the adipose tissue. Until recently, the adipose tissue was 
considered to play a passive role in the body by merely acting as a 
storage depot for fat; however, adipocytes are involved actively in 
maintaining the energy balance in the body, participating in processes 
such as satiety, bone function and reproduction. Most of these functions 
4are carried out via proteins secreted by the cells from the adipose tissue 
capable of acting locally or at such other nonadipose tissues as muscle, 
liver and stomach tissues, as well as on nervous, immune and vascular 
systems, even on bone turnover [8]. To fully understand the physiological 
functions of intra-abdominal adipose tissue in pathologies related to insulin 
resistance as obesity and PCOS, and to address whether in the adipose 
tissue of obese women with and without PCOS there are differentially 
expressed proteins, in this preliminary work we have optimised a protocol 
for IEF with IPGs 3-10 and 6-11 in samples from human intra-abdominal 
adipose tissue and we have identified some proteins by MALDI-TOF MS.
Samples were obtained from morbidly obese women submitted to 
surgical treatment for obesity. Samples (from ten unaffected women) were 
cut into small pieces and frozen at -75°C until used. The homogenisation 
was performed using a Polytron PT-1200C directly in the lysis buffer: 8.4 
M urea, 2.4 M thiourea, 5% CHAPS, 50mM DTT and 1% IPG buffer 3-10 
(total volume 2 mL/g fat pad). Rabilloud et al. [9] reported that thiourea in 
combination with urea increases the solubility of proteins in IPGs and 
increases the number of proteins visualised in the second dimension. To 
improve lysis and protein solubilisation, this suspension was gently shaken 
for 60 min at room temperature, then centrifuged at 70,000 rpm for 1.5 
hours at 19°C using a TL-100 ultracentrifuge. When attempting to 
solubilise and separate proteins from abdominal omental adipose some 
difficulties arise due to the presence of large amounts (often > 50% of the 
tissue volume) of triglycerides. Thus, the soluble infranatant below the fat 
supernatant was carefully recovered, avoiding the unhomogenized 
5material at the bottom of the centrifuge tube. The protein concentration in 
the collected fraction was measured according to the Bradford dye-binding 
procedure [10]. The original protein extract was diluted in the rehydration 
solution containing 8 M urea, 2 M thiourea, 2% CHAPS, 0.5% IPG buffer, 
0.002% BPB and 10mM DTT (or 50mM DTT or 100 mM of hydroxyethyl 
dishulphide, HED, depending of the gel) before the IEF. For IPG 6-11, 100 
µg of proteins diluted in 100 µl of rehydration solution were applied by cup-
loading close to the anode [2]. For IPG 3-10, 80 µg of proteins were 
applied by in-gel sample rehydration [11,12] in 350 µl of the above 
solution. The experiments were performed in duplicate for each condition 
and pH range. The strips (18 cm) were focused at 0.05 mA/IPG strip in the 
IPGphor IEF System (Amersham Biosciences, AB). The running 
conditions for IPG 6-11 were: 0 - 300 V in 1 min, 300 V for 3h, 300 - 600 V 
for 2 h, 600 - 1000 V for 2 h, 1000 - 8000 V for 3 h and 8000 V to reach 
about 55 - 58 kVh. The running conditions for IPG strips 3-10 were those 
reported by Görg et al., [2] with minor modifications, including an 
additional step at 120 V for 1 h, and a 90 min ramp from 1000 V to 8000 V, 
instead of 30 min. The step at 8000 V is maintained until reaching about 
35 kVh. After IEF, the strips (pH 6-11 and 3-10) were equilibrated and 
SDS-PAGE was performed using a Protean II XL system (Bio-Rad). Gels 
(12.5%) in a format of 185 x 200 x 1 mm were fixed overnight and silver 
stained. 
Horizontal streaking at the alkaline region of 2-DE maps is very 
often observed. This streaking is due to: (i) the loss of reducing agent in 
the basic part of the IPG strip, together with oxidation of the protein thiol 
6groups [2]; and (ii) water transport to the anode due to a reverse 
electroendosmotic flow [3]. To circumvent the first drawback, some 
authors introduce a paper wick immersed in DTT at the cathode during 
focusing to alleviate the loss of DTT in the basic part [4, 13]. With regard 
to water transport, addition of 10% isopropanol [3] or an 
isopropanol/glycerol mixture to the rehydration solution has been 
proposed as a solution [4]. Other authors have simplified the procedure for 
analysing very alkaline proteins by decreasing the total focusing time to a 
minimum (increasing the voltage to 8000 V to shorten the time required to 
reach the steady state) [5, 14].
For samples from human abdominal omental adipose tissue, 
replacing DTT by HED (DeStreak Reagent from AB) in the rehydration and 
sample solution when using Immobiline DryStrips 6-11, resulted in a 
relevant improvement in separation efficiency (Fig. 1), confirming the 
findings of Olsson and co-workers in which HED was shown to eliminate 
the horizontal streaking and to simplify the spot patterns in basic gradient 
[1]. Fig. 1 shows that horizontal streaking along with numerous spot trains 
disappear when HED is employed instead of DTT. More proteins can be 
visualised, as the intensity and number of spots increase. The majority of 
these spots are better defined and smaller. Moreover, the 2-DE map in 
Fig. 1C is better focused as compared to the maps in Fig. 1A and 1B. HED 
quantitatively oxidizes protein thiol groups to disulfide yielding a single 
protein species without any unwanted side reactions, therefore improving 
gel reproducibility [1].
7As shown in Fig. 2, 2-DE maps are notably improved when HED is 
added to the rehydration solution of wide IPG 3-10 strips. In this case in-
gel sample rehydration [11, 12] was employed instead of cup-loading, as 
in our hands the former performs better in the aforementioned pH range; 
however, the resulting spot patterns are comparable (data not shown). 
Serum albumin is the most abundant protein in the adipose tissue (spot 
labelled as number 1 in Fig. 2). Despite that 2-DE gels easily become 
overloaded with this protein, the protocol used to optimise IEF for adipose 
tissue has greatly enhanced the focusing of serum albumin.
In the rehydration solution for both IPG 3-10 and 6-11, HED 
concentrations other than 100mM, namely 50 mM and 200 mM, were 
tested, and the three conditions led to very similar spot patterns (results 
not shown).
The employ of PDQuest software (Bio-Rad) to detect spots in the 
gel images was assayed according to the manufacturer’s instructions. For 
IPG 3-10, the program detected 110 and 123 more spots when HED was 
added to the rehydration solution instead of 10 mM DTT and 50mM DTT, 
respectively, using the same spot detection parameters. For IPG 6-11 only 
the map in Fig. 1C was analysed with PDQuest, which detected 488 spots. 
The spots of interest were excised from the gel and submitted to 
tryptic digestion according to a protocol based on that from Shevchenko et 
al. [15] with minor variations. The resulting digestion solutions were 
collected and spotted on a 400 m AnchorChip MALDI probe (Bruker-
Daltonics, Bremen, Germany) together with the appropriate matrix solution 
and allowed to dry at room temperature. Samples were measured on a 
8Bruker Reflex IV MALDI-TOF mass spectrometer (Bruker-Daltonics) in 
positive ion reflector mode. Mass measurements were performed 
automatically under the control of a fuzzy logic engine. Each spectrum 
was internally calibrated with the masses of two trypsin autolysis products 
at m/z = 842.510 and m/z = 2211.105 to reach a typical mass 
measurement accuracy of ±30 ppm. The measured tryptic peptide masses 
were transferred through MS BioTools program (Bruker-Daltonics) as 
inputs to search the NCBInr database using Mascot software 
(MatrixScience, London, UK). No restrictions were placed on the species 
of origin of the protein and no variable modifications were allowed. Up to 
one missed tryptic cleavage was considered and a mass accuracy of 50 
ppm was used for all tryptic-mass searches. Some of the identified 
proteins are listed in Table 1.
Several 2-DE maps of mouse white adipose tissue proteins have 
been reported [6, 16], while related proteomic approaches have been 
applied to human cultured preadipocytes and adipocytes exclusively [17]. 
In this study we have optimized the sample preparation procedure for the 
proteomic analysis of human intra-abdominal adipose tissue using two 
different IPG strips and extended the analysis region to include the 
alkaline range.
9Legends to the Figures
Figure 1. 2-DE gel (pH 6-11) from 100 µg of human intra-abdominal 
adipose tissue focused in the presence of 10 mM DTT (A), 50 mM DTT (B) 
and 100 mM HED (C) in the rehydration and sample solutions. The 
indicated spots were picked and digested for protein identification (Table 
1).
Figure 2. Protein pattern (pH 3-10) from 80 µg of human intra-abdominal 
adipose tissue focused in the presence of 10mM DTT (A), 50 mM DTT (B) 
and 100 mM HED (C) in the rehydration solution. The indicated spots were 






Table 1. Protein identified by MALDI peptide mapping of indicated spots in 
Fig.1 and 2.
Spot no. Protein identity Accesion no. Theoretical Theoretical
Mr (Da) pI
1 Human serum albumin gi|4389275 67988 5.69
2 Actin, gamma 1 propeptide gi|4501887 42108 5.31
3 Glycerol-3-phosphate dehydrogenase 1 gi|21594877 38171 5.81
4 Lactate dehydrogenase B gi|4557032 36900 5.71
5 Annexin V gi|17391477 35959 4.94
6 Apolipoprotein A1 precursor gi|4557321 30759 5.56
7 Annexin I gi|4502101 38918 7.57
8 Enolase 1 gi|4503571 47481 7.01
9 Cytosolic malate dehydrogenase gi|5174539 36631 6.91
10 Biliverdin reductase B gi|544759 21960 7.31
11 Annexin A2 gi|16306978 38822 7.57
12 Transketolase gi|4507521 68519 7.58
13 Aldolase A gi|229674 39720 8.39
14 Peroxiredoxin 1 gi|4505591 22324 8.27
15 Long-chain fatty-acid-Coenzyme A ligase 2 gi|11276083 78919 6.81
16 Immunoglubulin heavy chain gamma gi|2765425 53379 8.74
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